EAM

Exome Asset Management Portfolio holdings

AUM $110M
1-Year Est. Return 24.83%
This Quarter Est. Return
1 Year Est. Return
+24.83%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$110M
AUM Growth
-$1.32M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
78
New
Increased
Reduced
Closed

Top Buys

1
+$4.75M
2
+$2.49M
3
+$2.48M
4
WAY
Waystar Holding Corp
WAY
+$1.92M
5
TXG icon
10x Genomics
TXG
+$1.9M

Top Sells

1
+$4.73M
2
+$3.09M
3
+$2.93M
4
SVRA icon
Savara
SVRA
+$2.32M
5
ANAB icon
AnaptysBio
ANAB
+$2.26M

Sector Composition

1 Healthcare 97.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DYN icon
26
Dyne Therapeutics
DYN
$2.38B
$1.87M 1.39%
195,933
-62,458
RGNX icon
27
Regenxbio
RGNX
$627M
$1.86M 1.38%
226,060
-179,221
UHS icon
28
Universal Health Services
UHS
$13.1B
$1.83M 1.36%
+10,100
VERA icon
29
Vera Therapeutics
VERA
$1.9B
$1.81M 1.34%
+76,700
CRNX icon
30
Crinetics Pharmaceuticals
CRNX
$3.93B
$1.8M 1.34%
62,700
+11,405
APLS icon
31
Apellis Pharmaceuticals
APLS
$3.42B
$1.71M 1.27%
+98,600
EWTX icon
32
Edgewise Therapeutics
EWTX
$1.6B
$1.63M 1.21%
124,470
+53,032
BCRX icon
33
BioCryst Pharmaceuticals
BCRX
$1.43B
$1.55M 1.15%
172,883
+112,283
CLDX icon
34
Celldex Therapeutics
CLDX
$1.87B
$1.49M 1.1%
+73,000
GOSS icon
35
Gossamer Bio
GOSS
$510M
$1.35M 1%
1,097,999
GPCR icon
36
Structure Therapeutics
GPCR
$1.6B
$1.11M 0.83%
53,744
-49,200
LEGN icon
37
Legend Biotech
LEGN
$5.95B
$1.03M 0.77%
+29,100
MBX
38
MBX Biosciences
MBX
$647M
$720K 0.54%
63,076
-70,037
ALVO icon
39
Alvotech
ALVO
$2.63B
$715K 0.53%
78,372
-11,728
NAMS icon
40
NewAmsterdam Pharma
NAMS
$4.05B
$662K 0.49%
+36,574
CMPS
41
Compass Pathways
CMPS
$629M
$598K 0.44%
+213,544
ESTA icon
42
Establishment Labs
ESTA
$1.42B
$560K 0.42%
13,100
VYNE icon
43
VYNE Therapeutics
VYNE
$9.44M
$345K 0.26%
208,970
-253,831
TIL icon
44
Instil Bio
TIL
$133M
$337K 0.25%
+16,200
ANAB icon
45
AnaptysBio
ANAB
$989M
$333K 0.25%
15,000
-101,623
ELDN icon
46
Eledon Pharmaceuticals
ELDN
$198M
$309K 0.23%
114,145
LQDA icon
47
Liquidia Corp
LQDA
$2.07B
$255K 0.19%
+20,500
ABUS icon
48
Arbutus Biopharma
ABUS
$855M
$233K 0.17%
+75,484
ELEV
49
DELISTED
Elevation Oncology
ELEV
$40.5K 0.03%
+110,353
TRVI icon
50
Trevi Therapeutics
TRVI
$1.3B
– –
-163,738
1
2
3 4